Boston Scientific (BSX) Guides to Double Digit EPS Growth Through 2020, PT Raised to $46 at Canaccord Genuity
Tweet Send to a Friend
Canaccord Genuity analyst Jason Mills raised the price target on Boston Scientific (NYSE: BSX) to $46.00 (from $43.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
